Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells.
about
Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cellsCarcinoid tumorsPI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsLithium ions: a novel treatment for pheochromocytomas and paragangliomasInhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.Growth arrest signaling of the Raf/MEK/ERK pathway in cancer.Focal adhesion kinase, a downstream mediator of Raf-1 signaling, suppresses cellular adhesion, migration, and neuroendocrine markers in BON carcinoid cellsLithium inhibits carcinoid cell growth in vitroValproic acid induces Notch1 signaling in small cell lung cancer cellsThe roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progressionValproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cellsInhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumorsCo-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.Signaling mechanisms in neuroendocrine tumors as targets for therapy.Inhibition of the PI3K pathway suppresses hormonal secretion and limits growth in pheochromocytoma cells.Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction.Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids.Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathwaysSynergistic effect of pasireotide and teriflunomide in carcinoids in vitro.Tumor suppressor role of notch1 and raf-1 signaling in medullary thyroid cancer cells.Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cellsTautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathwayTautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3beta.Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumorsFollicular thyroid cancer cell growth inhibition by proteosome inhibitor MG132Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.Octreotide-functionalized and resveratrol-loaded unimolecular micelles for targeted neuroendocrine cancer therapy.AKT and PTEN expression in human gastrointestinal carcinoid tumors.MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.Current understanding of the molecular biology of pancreatic neuroendocrine tumors.MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition.Generation of Novel Thyroid Cancer Stem-Like Cell Clones: Effects of Resveratrol and Valproic Acid.Notch1 Signaling Regulates the Aggressiveness of Differentiated Thyroid Cancer and Inhibits SERPINE1 Expression.The Phosphatidylinositol 3-kinase/Akt Signaling Pathway in Neuroendocrine Tumors.Leflunomide suppresses growth in human medullary thyroid cancer cells.Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro.Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines.
P2860
Q24323223-2C5A310C-DCC0-4FEA-9F00-0EA0CFBB5C74Q24614827-419E1BFB-BF06-4072-922F-AF5D79A075F8Q26862544-6359E7DA-0A70-4206-8A14-4BE473984C00Q28582101-8BD0F69E-EB97-4227-876A-98C440B92749Q33804934-C7B58B63-AF1D-494D-8E9E-CB8F391AB39FQ33836237-5B993DD1-0ECA-47C6-9F2F-FEF52D6445ADQ33861019-CD0CD39A-F3C0-4782-9907-50DBAAB59454Q33942103-AC0D1B2D-0B38-46AA-99E4-787CED0B4D36Q33976203-3AFE32EB-BA91-4ADB-BF00-2079429C25D1Q33978070-AF38A5A9-8BB5-4210-80FF-F70B5B6A5EB1Q33998266-969A94E2-0FEF-4FC0-BBEB-234D6E0A3F4DQ34048712-BDAA6441-1434-4B33-9428-1383086BEC91Q34446374-3DA0400D-740B-4E44-A866-8C6B8B1A7C4BQ34447484-1D6B08F5-C7A0-4D49-A395-CDCB62905130Q34939579-3D4F5365-2729-48B1-9320-931638DDC816Q35523958-6984A710-39AD-4014-A5CF-BAD6E1E233C2Q36167254-BE06E42D-5922-44F0-9DC2-FF7B35D2390EQ36334183-5657C093-6481-40D8-B368-46A62FE85650Q36536629-3CE8262E-4765-4F76-A155-DF94B7A427DAQ36790872-5F5FF18D-9359-47B2-9D2B-53F33F823359Q37001327-140D752C-5ECF-46C8-87E8-70A20FB5936FQ37089077-8D83B157-C761-4B4E-89DD-3B0074A86938Q37148789-6754D9ED-DAC9-4F4C-9A23-C41BA238A9EDQ37161813-F1337964-FD12-457D-AF64-713458DC0FE0Q37179117-31F97A81-BB59-44A7-A32A-1A80F6966485Q37314468-F3ABAA77-1DF3-47B2-AF08-B827D17CDF67Q37332674-36308D4B-176C-4865-82D8-FA9ED1A4AF3EQ37339815-D800CAE2-799A-42D2-BF5B-728149301100Q37372483-D2FDF00E-EF0D-442E-BF1F-0123D07D6C49Q37403020-AD74792E-0698-4AC4-B832-E1241079FE9BQ37418940-7890D919-92B3-476F-8C5D-D4F7D7AEB3A6Q37480580-B1D275FE-0A5C-4007-9D2F-8CDB3A2CF5EEQ38120515-46288F4C-9E67-4471-98D6-F276F132E5BEQ38287178-212F45FE-199F-4036-A8D4-91AF2362CD9AQ38779687-B29AEF65-4CB6-4B5A-8B6B-4F7B3686A08AQ38796455-0AAFCB20-BBA3-4BDA-AA33-98BB79618E39Q39042894-F6E73834-A3D0-4C58-AACA-4B6B4C1B896FQ39132342-EA3474D9-C4CC-447B-959A-D140D656E135Q39245623-DF1F8408-81E0-4E68-B792-FC20A0ECEBE5Q39328101-25990664-C90B-4312-ADBB-FAA94F616F29
P2860
Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Raf-1 activation suppresses ne ...... trointestinal carcinoid cells.
@en
Raf-1 activation suppresses ne ...... trointestinal carcinoid cells.
@nl
type
label
Raf-1 activation suppresses ne ...... trointestinal carcinoid cells.
@en
Raf-1 activation suppresses ne ...... trointestinal carcinoid cells.
@nl
prefLabel
Raf-1 activation suppresses ne ...... trointestinal carcinoid cells.
@en
Raf-1 activation suppresses ne ...... trointestinal carcinoid cells.
@nl
P2093
P2860
P356
P1476
Raf-1 activation suppresses ne ...... trointestinal carcinoid cells.
@en
P2093
Herbert Chen
Jennifer E Carpenter
Rebecca S Sippel
Sara Lagerholm
P2860
P304
P356
10.1152/AJPGI.00420.2002
P577
2003-08-01T00:00:00Z